Home MediciNova's Ibudilast And The Phase IIb Trial Offer Steady Outlook
 

Keywords :   


MediciNova's Ibudilast And The Phase IIb Trial Offer Steady Outlook

2016-01-19 02:56:44| Biotech - Topix.net

I/we have no positions in any stocks mentioned, but may initiate a long position in MNOV over the next 72 hours. I wrote this article myself, and it expresses my own opinions.

Tags: offer trial phase outlook

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
29.09When to recline and how to share armrests: Rules for avoiding a mid-flight row
29.09Atlantic Tropical Weather Outlook
29.09Eastern North Pacific Tropical Weather Outlook
28.09Hurricane Isaac Graphics
28.09Hurricane Isaac Forecast Discussion Number 12
28.09Tropical Storm Joyce Graphics
28.09Hurricane Isaac Wind Speed Probabilities Number 12
28.09Hurricane Isaac Forecast Advisory Number 12
More »